Serotonin Transporters in Alcoholism
PET Evaluation of Serotonin Transporters Using [C-11] DASB in Alcoholism
2 other identifiers
observational
60
1 country
1
Brief Summary
This study will compare serotonin transporter proteins in people with alcoholism and healthy volunteers to examine how these proteins may be related to the inability of people with alcoholism to appropriately regulate their alcohol consumption. Serotonin transporters regulate levels of the brain chemical serotonin. Problems in this regulation have been implicated in alcoholism. Healthy normal volunteers and people who suffer from alcoholism who are between 18 and 75 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, psychiatric diagnostic interview, blood and urine tests, an electrocardiogram, urine toxicology screen, and written psychological evaluations. Participants undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning to measure serotonin transporter levels in the brain. PET uses small amounts of a radioactive chemical called a tracer that "labels" the serotonin transporters in the brain. The tracer used in this study is \[11C\]DASB. For the procedure, the subject lies on the scanner bed. A special mask is fitted to the head and attached to the bed to help keep the subject's head still during the scan so the images will be clear. A brief scan is done just before the radioactive tracer is injected. This scan provides measures of the brain that will help in the precise calculation of information from subsequent scans. After the tracer is injected through a catheter (plastic tube) placed in the arm, pictures are taken for about 2 hours. MRI uses a magnetic field and radio waves to produce pictures of brain structure. The subject lies on a bed that slides into the tube-like scanner, wearing earplugs to muffle loud noises the machine makes when the magnetic fields are switched. The scan takes about an hour, during which time the subject can communicate with the technician.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2004
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
June 15, 2004
CompletedFirst Posted
Study publicly available on registry
June 16, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2006
CompletedMarch 4, 2008
July 1, 2006
June 15, 2004
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Age: 18-75
- DSM-IV criteria for alcohol dependence or alcohol abuse.
- Age: 18-75
You may not qualify if:
- PATIENTS AND CONTROLS:
- Other current DSM-IV Axis I diagnostic criteria than alcohol dependence or alcohol abuse.
- Psychotropic medication or other drugs that may cross the blood brain barrier.
- Serious organic disease e.g. liver disease.
- Claustrophobia.
- Pregnancy.
- Prior participation in other research protocols within the past year such that a radiation exposure together with the present study would exceed the annual limits.
- Any condition that increases risk for MRI (e.g., pacemaker, metallic foreign body in the eye, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Mental Health (NIMH)
Bethesda, Maryland, 20892, United States
Related Publications (1)
Fujita M, Charney DS, Innis RB. Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations. Biol Psychiatry. 2000 Oct 15;48(8):801-12. doi: 10.1016/s0006-3223(00)00960-4.
PMID: 11063976BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 15, 2004
First Posted
June 16, 2004
Study Start
June 1, 2004
Study Completion
July 1, 2006
Last Updated
March 4, 2008
Record last verified: 2006-07